Compounds useful in inhibiting endo-
exonuclease activity and treating
cancer have the formula (I):wherein R3 is selected from the group consisting of loweralkyl, oxyalkyl, cycloalkyl,
aryl, heteroaryl, heterocycloalkyl, aminoalkyl or a
halogen; R4 is selected from the group consisting of H, loweralkyl, oxyalkyl, cycloalkyl,
aryl, heteroaryl, heterocycloalkyl, aminoalkyl or a
halogen; and wherein R5 is a loweralkyl; or formula (II):wherein R1 is selected from the group consisting of loweralkyl, oxyalkyl, cycloalkyl,
aryl, heteroaryl, heterocycloalkyl, aminoalkyl or
halogen; R2 is selected from the group consisting of H, loweralkyl, oxyalkyl, cycloalkyl, aryl, heteroaryl, heterocycloalkyl, aminoalkyl or halogen; and wherein R5 is a loweralkyl comprising a linear
carbon chain of at least two carbons connecting the first “O” to the second “O”.